Koers Regencell Bioscience Holdings Limited
Aandelen
RGC
KYG7487R1002
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,27 USD | +13,33% | -7,54% | -49,81% |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 300 mln. 280 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -7 mln. -6,55 mln. | Nettowinst (verlies) 2023 | -5 mln. -4,68 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 15,65 mln. 14,64 mln. | Nettoliquiditeiten 2023 | 11,1 mln. 10,39 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-59,5
x | K/w-verhouding 2023 |
-51,1
x | Werknemers | 12 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 11,24% |
1 dag | +13,33% | ||
1 week | -7,54% | ||
1 maand | +17,11% | ||
3 maanden | -33,38% | ||
6 maanden | -66,92% | ||
Lopend jaar | -49,81% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wai Hong Chung
COO | Chief Operating Officer | 46 | - |
Yi-Chung Chao
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-10-20 |
Yat-Pui Au
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wing Yan Lo
BRD | Director/Board Member | 63 | 13-12-21 |
Yi-Chung Chao
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-10-20 |
- | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 5,27 | +13,33% | 1 196 |
29-04-24 | 4,65 | -13,08% | 5 027 |
25-04-24 | 5,35 | +4,90% | 1 147 |
24-04-24 | 5,1 | -10,53% | 2 609 |
23-04-24 | 5,7 | -11,49% | 27 364 |
uitgestelde koers Nasdaq, 30 april 2024 om 22:30 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-49,81% | 68,58 mln. | |
+0,67% | 42,19 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+6,55% | 24,63 mld. | |
-21,66% | 18,2 mld. | |
+29,96% | 12,01 mld. | |
-1,57% | 11,76 mld. | |
+16,03% | 10,4 mld. | |
-4,80% | 9,94 mld. |